Is Tricuspid Regurgitation after TAVR Significant?

Courtesy of Dr. Carlos Fava.

Severe or moderate mitral regurgitation is associated to worse evolution after TAVR. However, we should not forget the tricuspid valve that, even though not extensively researched, is also associated to a negative impact in its evolution.

Más coincidencias de las esperadas entre válvulas bicúspides y tricúspidesA meta-analysis of 12 studies with a total 41485 patients was carried out.

 

Early mortality (up to 6 months) was 1.8 times higher with severe or ≥moderate tricuspid regurgitation (OR, 1.80; 95% CI, 1.01 to 3.19; P=0.05). Between 6 and 30 months after TAVR, it was 1.9 times higher (HR/OR, 1.96; 95% CI, 1.35 to 2.85; P = 0.0004).


Read also: ¿Metformin to Treat Abdominal Aortic Aneurysms?


A second meta-analysis of 7 homogeneous studies was carried out and mortality between 6 and 30 months was 2.25 times higher (HR,2.25; 95% CI, 1.20–4.24; P= 0.01).

 

Conclusion

Significant tricuspid regurgitation (severe or ≥moderate) is associated to an approximate two-fold increase in early or mid-term all-cause mortality in patients with aortic stenosis undergoing TAVR.

 

Courtesy of Dr. Carlos Fava.

 

Original title: Impact of concurrent tricuspid regurgitation on mortality after transcatheter aortic-valve implantation.

Reference: Hisato Takagi, et al. Catheter Cardiovasc Interv. 2018;1–8. DOI: 10.1002/ccd.27948.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Transcatheter Paravalvular Leak Closure: Mid-Term Outcomes and Prognostic Factors

Paravalvular leaks (PVL) are a frequent complication following surgical valve replacement, occurring in 5% to 18% of prosthetic valves. Incidence varies according to valve...

After a Major Bleeding Event in Atrial Fibrillation: When Should Left Atrial Appendage Closure Be Considered?

Atrial fibrillation (AF) in patients who experience a major bleeding event represents a complex clinical scenario in which percutaneous left atrial appendage closure (LAAC)...

New Balloon-Expandable Aortic Valve: 30-Day Outcomes in Patients with Small Aortic Annulus

As transcatheter aortic valve implantation (TAVI) continues to expand toward younger patients with longer life expectancy, factors such as valve hemodynamic performance, durability, and...

TAVI in small aortic annulus: self-expanding or balloon-expandable valve in the long term?

Patients with a small aortic annulus (a predominantly female population with a higher risk of prosthesis–patient mismatch) represent a particularly challenging subgroup within TAVI....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

Transcatheter Paravalvular Leak Closure: Mid-Term Outcomes and Prognostic Factors

Paravalvular leaks (PVL) are a frequent complication following surgical valve replacement, occurring in 5% to 18% of prosthetic valves. Incidence varies according to valve...

After a Major Bleeding Event in Atrial Fibrillation: When Should Left Atrial Appendage Closure Be Considered?

Atrial fibrillation (AF) in patients who experience a major bleeding event represents a complex clinical scenario in which percutaneous left atrial appendage closure (LAAC)...